CytoMed Therapeutics Ltd

GDTC

Company Profile

  • Business description

    CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

  • Contact

    1 Commonwealth Lane
    No. 08-22 One Commonwealth
    Singapore149544
    SGP

    T: +65 62507738

    https://w2.cytomed.sg

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    42

Stocks News & Analysis

stocks

Big-four bank earnings surge but revenue growth elusive

Shares sell off after results.
stocks

This ASX supermarkets business is now underperforming its largest competitor

Competition restrains long-term margins.
stocks

Apple earnings: Let the iPhone 17 cycle rip

We raise our fair value estimate for Apple stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,923.8030.30-0.34%
CAC 407,981.47133.37-1.64%
DAX 4024,035.56256.82-1.06%
Dow JONES (US)49,128.96370.31-0.75%
FTSE 10010,363.9314.89-0.14%
HKSE26,095.88319.351.24%
NASDAQ25,058.8455.60-0.22%
Nikkei 22559,513.12228.200.38%
NZX 50 Index13,097.6858.480.45%
S&P 5007,207.7222.40-0.31%
S&P/ASX 2008,697.1028.50-0.33%
SSE Composite Index4,112.164.650.11%

Market Movers